Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2020 Sep;26(9):1242-1247.
doi: 10.1016/j.cmi.2020.05.041. Epub 2020 Jun 9.

Risk factors for disease progression in patients with mild to moderate coronavirus disease 2019-a multi-centre observational study

Y Cen  1 , X Chen  2 , Y Shen  3 , X-H Zhang  4 , Y Lei  5 , C Xu  6 , W-R Jiang  7 , H-T Xu  8 , Y Chen  9 , J Zhu  10 , L-L Zhang  11 , Y-H Liu  12
Affiliations
Observational Study

Risk factors for disease progression in patients with mild to moderate coronavirus disease 2019-a multi-centre observational study

Y Cen et al. Clin Microbiol Infect. 2020 Sep.

Abstract

Objectives: Since December 2019, the novel coronavirus disease 2019 (COVID-19) that emerged in Wuhan city has spread rapidly around the world. The risk for poor outcome dramatically increases once a patient progresses to the severe or critical stage. The present study aims to investigate the risk factors for disease progression in individuals with mild to moderate COVID-19.

Methods: We conducted a cohort study that included 1007 individuals with mild to moderate COVID-19 from three hospitals in Wuhan. Clinical characteristics and baseline laboratory findings were collected. Patients were followed up for 28 days for observation of disease progression. The end point was the progression to a more severe disease stage.

Results: During a follow up of 28 days, 720 patients (71.50%) had recovered or were symptomatically stable, 222 patients (22.05%) had progressed to severe disease, 22 patients (2.18%) had progressed to the critically ill stage and 43 patients (4.27%) had died. Multivariate Cox proportional hazards models identified that increased age (hazard ratio (HR) 2.56, 95% CI 1.97-3.33), male sex (HR 1.79, 95% CI 1.41-2.28), presence of hypertension (HR 1.44, 95% CI 1.11-1.88), diabetes (HR 1.82, 95% CI 1.35-2.44), chronic obstructive pulmonary disease (HR 2.01, 95% CI 1.38-2.93) and coronary artery disease (HR 1.83, 95% CI 1.26-2.66) were risk factors for disease progression. History of smoking was protective against disease progression (HR 0.56, 95% CI 0.34-0.91). Elevated procalcitonin (HR 1.72, 95% CI 1.02-2.90), urea nitrogen (HR 1.72, 95% CI 1.21-2.43), α-hydroxybutyrate dehydrogenase (HR 3.02, 95% CI 1.26-7.21) and D-dimer (HR 2.01, 95% CI 1.12-3.58) at baseline were also associated with risk for disease progression.

Conclusions: This study identified a panel of risk factors for disease progression in individuals with mild to moderate COVID-19.

Keywords: Co-morbidity; Coronavirus disease 2019; Disease progression; Laboratory findings; Risk factors.

PubMed Disclaimer

References

    1. Chen N., Zhou M., Dong X., Qu J., Gong F., Han Y. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020 epub ahead of print. - PMC - PubMed
    1. Guan W.J., Ni Z.Y., Hu Y., Liang W.H., Ou C.Q., He J.X. China medical treatment expert group for, clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020 epub ahead of print. - PMC - PubMed
    1. Yang X., Yu Y., Xu J., Shu H., Xia J., Liu H. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020 epub ahead of print. - PMC - PubMed
    1. Li Tan Q.W., Zhang D., Ding J., Huang Q., Tang Y.-Q., Wang Q. Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study. medRxiv. 2020 doi: 10.1101/2020.03.01.20029074. - DOI - PMC - PubMed
    1. WHO Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected. 2020. https://www.who.int/publications-detail/clinical-management-ofsevere-acu... Available at:

Publication types

MeSH terms

Substances